29 June 2020
Sidley Represents Kangji Medical in Hong Kong IPO
Advising firms
Deal team
11 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Mengyu Lu Lead | Sidley | Partner | Not stated | Not stated |
| Meng Ding Lead | Sidley | Partner | Not stated | Not stated |
| Angela Zhang | Sidley | Counsel | Not stated | Not stated |
| Samantha Peng | Sidley | Senior associate | Not stated | Not stated |
| Sierra Tao | Sidley | Other | Not stated | Not stated |
| Jingwen Dong | Sidley | Other | Not stated | Not stated |
| Guanlin Wang | Sidley | Associate | Not stated | Not stated |
| Jenny Han | Sidley | Associate | Not stated | Not stated |
| Bill Feng | Sidley | Associate | Not stated | Not stated |
| Eason Qu | Sidley | Other | Not stated | Not stated |
| Xinyang Li | Sidley | Other | Not stated | Not stated |
Stated terms
- Stated value
- USD 404m (US$404 million)
- What the figure measures
- Issue size
- Client
- Kangji Medical Holdings LimitedIssuer
- Counterparties
- Goldman Sachs (Asia) LLC (Underwriters)
CLSA Capital Markets Limited (Underwriters)
Merrill Lynch Far East Limited (Underwriters)
TPG Capital (Investor)
LYFE Capital (Investor)
Fidelity Investments (Investor)
BlackRock Funds (Investor)
Lake Bleu Prime (Investor)
Hillhouse Capital Group (Investor)
Cormorant (Investor)
OrbiMed Capital LLC (Investor)
Oaktree Capital Management (Investor)